NRX Pharmaceuticals Inc (NRXP)

[mc67]

$NRXP $RLFTF (opinion) by WONG on Yh0 -
Sounds like Dr. J is getting ticked off at this point too. Look at the PR. He says we responded saying you have a two fold advantage of surviving with our treatment and we are sharing this new analysis with other health agencies globally. Sound like he is saying we are done playing your game and we will get approval from countries that actually need and want the help.

In our regulatory response, we presented a statistical analysis showing a statistically significant two-fold increase in odds of survival at 60 days post treatment among those treated with aviptadil, compared to those treated with placebo. The analysis considers all patients at all sites of care and controls for baseline severity of illness using the baseline severity criteria that were prespecified in our protocol. We are similarly sharing these results with partners and regulators around the globe at the request of Health Ministries as the Delta and subsequent variants continue to escalate the COVID public health emergency.